These analyses demonstrated that HHIP was a key TSG controlling liver cancer cell proliferation and cell viability; in fact, only modest changes in cell viability were achieved when individually targeting MT1M, PZP, and TTC36 (Additional file 9: Fig. S8). Here, MT1M is linked to liver cancer.